tirzepatide maximum weight loss surmount trials A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% ✓ Semaglutide: 13.7% weight loss But weight loss isn't the SURMOUNT-1 Trial - Cardionerds Twitter

Incretin-like drugs mimic these hormones, and while we do not have any head-to-head trials, you can see from the informative Figure below, summarizing best results of this family of drugs to date, moving from single agonist GLP-1 to double and then triple (GLP-1-GIP-GCG), there is incremental body weight loss

L-Carnitine stacks well with most common supplements including protein powders, creatine, BCAAs, and pre-workout formulas

For the specific semaglutide methylcobalamin ODT formulation, using methylcobalamin makes pharmacological sense given the buccal absorption route

G., Morris, A

however, it was quickly discovered that they had a welcome side effect of weight loss